Erika Carmel Ltd - Asset Resilience Ratio
Erika Carmel Ltd (BCUR) has an Asset Resilience Ratio of 2.95% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how Erika Carmel Ltd's Asset Resilience Ratio has changed over time. Check BCUR strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Erika Carmel Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BCUR market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA931.00K | 2.95% |
| Total Liquid Assets | ILA931.00K | 2.95% |
Asset Resilience Insights
- Limited Liquidity: Erika Carmel Ltd maintains only 2.95% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Erika Carmel Ltd Industry Peers by Asset Resilience Ratio
Compare Erika Carmel Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM |
Medical Devices | 46.67% |
|
Medartis Holding AG
SW:MED |
Medical Devices | 0.00% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 34.47% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Respiri Ltd
AU:RSH |
Medical Devices | 0.46% |
Annual Asset Resilience Ratio for Erika Carmel Ltd (2022–2024)
The table below shows the annual Asset Resilience Ratio data for Erika Carmel Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 6.78% | ILA2.35 Million ≈ $6.31K |
ILA34.75 Million ≈ $93.16K |
-10.84pp |
| 2023-12-31 | 17.61% | ILA8.26 Million ≈ $22.15K |
ILA46.91 Million ≈ $125.76K |
-1.31pp |
| 2022-12-31 | 18.92% | ILA12.94 Million ≈ $34.69K |
ILA68.39 Million ≈ $183.34K |
-- |
About Erika Carmel Ltd
Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic probl… Read more